UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice
Aaron Lee(Imperial College London), Adnan Tufail(Moorfields Eye Hospital), Louise Downey(Hull and East Yorkshire Hospitals NHS Trust), Catherine Egan(Maine Farmland Trust), Sahar Al‐Husainy(Heart of England NHS Foundation Trust), Robin Hamilton(Moorfields Eye Hospital NHS Foundation Trust), Salim Natha(Wrightington, Wigan and Leigh NHS Foundation Trust), Cecilia S. Lee(University of Washington), Rehna Khan(Calderdale and Huddersfield NHS Foundation Trust), Christopher Brand(Royal Hallamshire Hospital), Robert L. Johnston(Cheltenham General Hospital), Clare Bailey(Bristol Eye Hospital), Toks Akerele(Hinchingbrooke Health Care NHS Trust), Martin McKibbin(Leeds Teaching Hospitals NHS Trust)
Cited by 47
Related Papers
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
|Ophthalmology Retina|2017|669
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|Nature Medicine|2020|665